Scientific publications

International Journal of Molecular Sciences, 2026
Plasma Proteomic Signatures of Glucose Metabolism Disturbances and Early Diabetes

Zieleniewska N., Jamiołkowski J., Malarstig A. et al.

Nature Medicine, 2026
AI framework for multidisease detection via retinal imaging

Zhang X., Li Q., Liang Y. et al.

The American Journal of Clinical Nutrition, 2026
Plasma proteomics enhances heart failure risk prediction among individuals with type 2 diabetes: a prospective cohort study

Yu H., Zhang J., Qian F. et al.

Journal of Inherited Metabolic Disease, 2026
Multimodal Noninvasive Biomarker Characterization of Structural and Functional Alterations in ADSS1 ‐Deficient Myopathy

Yekedüz M., van Gool R., van der Heijden H. et al.

Nature Immunology, 2026
A spatially coordinated keratinocyte–fibroblast circuit recruits MMP9+ myeloid cells to drive type I interferon-driven inflammation in photosensitive autoimmunity

Wang Y., Afshari K., Haddadi N. et al.

Clinical and Translational Science, 2026
GlycA as an Effect Modifier of Protein–Mortality Associations: A Prospective Cohort Study

Wang X., Qiao Z., Tao C. et al.

American Journal of Preventive Cardiology, 2026
Associations of VICTORION-1 PREVENT eligibility with subclinical cardiovascular and inflammatory damage in a European population-based cohort

Wang N., Bhatt D., Xhaard C. et al.

Neurobiology of Disease, 2026
A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke

Tan H., Gong H., Li H. et al.

npj Dementia, 2026
Targeted profiling of the serum proteome associates increased FGF-23 levels with postoperative delirium in cardiac surgical patients

Simon C., Kelly Graves O., Williams V. et al.

Clinical Cardiology, 2026
Plasma EDA2R and Risk of Cardiovascular Diseases and All‐Cause Mortality: Analysis of the UK Biobank Cohort

Ruan Z., Tu J., Xu H. et al.

JCI Insight, 2026
Pan-cancer polygenic risk score associates with cancer susceptibility following kidney transplantation

Ritari J., Hyvärinen K., Jahnukainen K. et al.

Alzheimer's Research & Therapy, 2026
Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ+ and Aβ- dementia with Lewy bodies patients

Oosthoek M., In ’t Veld S., Vermunt L. et al.

Neurology Neuroimmunology & Neuroinflammation, 2026
Emerging CSF and Serum Biomarkers in Multiple Sclerosis

Oechtering J., Schaedelin S., Maleska Maceski A. et al.

npj Parkinson's Disease, 2026
Plasma proteomics for Parkinson’s disease classification: cross-cohort benchmarking of proteomic, transcriptomic, and multimodal models

Minster N., Jafri S.

Leukemia & Lymphoma, 2026
Targeting the IL-8 axis in high-risk myelodysplastic syndromes: a clinical experience with antibody blockade combined with decitabine/cedazuridine

Mina A., Calvo K., McKinnon K. et al.

Nature Biotechnology, 2026
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression

Marks A., Siu S., Bianchini F. et al.

Canadian Journal of Cardiology, 2026
Clinical and community factors' correlation with NT-proBNP in First Nations: a cross-sectional analysis of the CAHHM-FN cohort

Marchand M., Labiba Z., Schulze K. et al.

Cell Reports Medicine, 2026
Checkpoint blockade-related CNS adverse events are characterized by neurotoxic T helper cells with sustained neuroantigen reactivity

Ma Y., Zhang A., Lin J. et al.

Nature Medicine, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial

Li H., Xu Y., Chen Y. et al.

Neurobiology of Disease, 2026
Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity

Jin H., Meng L., Yulug B. et al.